CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.
Conatus Pharmaceuticals Inc. (the Company) held its annual
meeting of stockholders on June 22, 2017. The following is a
brief description of each matter voted upon at the meeting and
the number of votes cast for, withheld or against, the number of
abstentions and the number of broker non-votes with respect to
each matter, as applicable.
| 1. |
The election of two nominees to serve as Class I directors for a three-year term to expire at the 2020 annual meeting of stockholders. The following two Class I directors were re-elected by the votes indicated: |
| For | Withheld | Broker Non-Votes | |||
| Preston S. Klassen, M.D., M.H.S. | 10,682,583 | 83,026 | 9,784,331 | ||
| William R. LaRue | 10,685,899 | 79,710 | 9,784,331 |
| 2. |
The ratification of the selection of Ernst Young LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017. The selection was ratified by the votes indicated: |
| For | Against | Abstain | Broker Non-Votes | |||
| 20,442,986 | 63,850 | 43,104 |
About CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT)
Conatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease. The Company operates through commercialization and development of pharmaceutical products segment. The Company is engaged in developing emricasan, which is an orally active pan-caspase protease inhibitor for the treatment of patients with chronic liver disease. Emricasan has the potential to interrupt the progression of liver disease and provide treatment options in multiple areas of liver disease. Emricasan is designed to slow or halt the progression of chronic liver disease caused by fibrosis and cirrhosis. Emricasan works by inhibiting caspases, which are a family of related enzymes that plays as modulators of critical cellular functions, including functions that result in apoptosis and inflammation.
